Alhosin et al. Journal of Experimental & Clinical Cancer Research 2011, 30:41 http://www.jeccr.com/content/30/1/41 Page 8 of 10 12. Bestor TH: The DNA methyltransferases of mammals. Hum Mol Genet 2000, 9:2395-2402. 13. Hermann A, Gowher H, Jeltsch A: Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 2004, 61:2571-2587. 14. Suzuki MM, Bird A: DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 2008, 6:465-476. 15. Riggs AD, Pfeifer GP: X-chromosome inactivation and cell memory. Trends genet 1992, 8:169-174. 16. Jones PA, Baylin SB: The epigenomics of cancer. Cell 2007, 128:683-692. 17. Greger V, Debus N, Lohmann D, Höpping W, Passarge E, Horsthemke B: Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet 1994, 94:491-496. 18. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-428. 19. Jones PA, Baylin SB: The epigenomics of cancer. Cell 2007, 128:683-692. 20. Baylin SB, Ohm JE: Epigenetic gene silencing in cancer a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006, 6:107-116. 21. Fleuriel C, Touka M, Boulay G, Guerardel C, Rood BR, Leprince D: HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumours. Int J Biochem Cell Biol 2009, 41:26-33. 22. Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Esteller N, Baylin SB, Herman JG: Transcriptional silencing of the p73 gene in acute lymphoblastic leukaemia and Burkitt’s lymphoma is associated with 5’CpG island methylation. Cancer Res 1999, 59:3352-3356. 23. Kawano S, Miller CW, Gombart AF, Bartram CR, Matsuo Y, Asou H, Sakashita A, Said J, Tatsumi E, Koeffler HP: Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. Blood 1999, 94:1113-1120. 24. Kouzarides T: Chromatin modifications and their function. Cell 2007, 128:693-705. 25. Vaissière T, Sawan C, Herceg Z: Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res 2008, 659:40-48. 26. Bronner C, Fuhrmann G, Chédin FL, Macaluso M, Dhe-Paganon SD: UHRF1 links the histone code and DNA methylation to ensure faithful epigenetic memory inheritance. Genetics and Epigenetics 2009, 2:29-36. 27. McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T, Baylin SB: Silenced tumour suppressor genes reactivated byDNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res 2006, 66:3541-3549. 28. Fraga MF, Esteller M: Towards the human cancer epigenome: a first draft of histone modifications. Cell Cycle 2005, 4:1377-1381. 29. Fritzsche FR, Weichert W, Röske A, Gekeler V, Beckers T, Stephan C, Jung K, Scholman K, Denkert C, Dietel M, Kristiansen G: Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. BMC Cancer 2008, 8:381. 30. Song J, Noh JH, Lee JH, Eun JW, Ahn YM, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, Nam SW: Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS 2005, 113:264-268. 31. Smallwood A, Estève PO, Pradhan S, Carey M: Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev 2007, 21:1169-1178. 32. Wozniak RJ, Klimecki WT, Lau SS, Feinstein Y, Futscher BW: 5-Aza-2’- deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumour suppressor gene reactivation. Oncogene 2007, 26:77-90. 33. Cheng X, Blumenthal RM, Coordinated Chromatin Control: Structural and Functional Linkage of DNA and Histone Methylation. Biochemistry 2010, 49:2999-3008. 34. Hashimoto H, Horton JR, Zhang X, Cheng X: UHRF1, a modular multi- domain protein, regulates replication-coupled crosstalk between DNA methylation and histone modifications. Epigenetics 2009, 4:8-14. 35. Bronner C, Achour A, Arima Y, Chataigneau T, Saya H, Schini-Kerth VB: The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther 2007, 115:419-434. 36. Unoki M, Brunet J, Mousli M: Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochem Pharmacol 2009, 78:279-288. 37. Lorenzato M, Caudroy S, Bronner C, Evrard G, Simon M, Durlach A, Birembaut P, Clavel C: Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Pathol 2005, 36:1101-1107. 38. Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, Capurso G, Lattimore S, Akada M, Sunamura M, Prime W, Campbell F, Brentnall TA, Costello E, Neoptolemos J, Lemoine NR: Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 2005, 129:1454-1463. 39. Unoki M, Kelly JD, Neal DE, Ponder BAJ, Nakamura Y, Hamamoto R: UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer 2009, 101:98-105. 40. Unoki M, Daigo Y, Koinuma J, Tsuchiya E, Hamamoto R, Nakamura Y: UHRF1 is a novel diagnostic marker of lung cancer. Br J Cancer 2010, 103:217-222. 41. Hopfner R, Mousli M, Oudet P, Bronner C: Overexpression of ICBP90, a novel CCAAT binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression. Anticancer Res 2002, 22:3165-3170. 42. Daskalos A, Oleksiewicz U, Filia A, Nikolaidis G, Xinarianos G, Gosney JR, Malliri A, Field JK, Liloglou T: UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer. Cancer 2011, 117:1027-1037. 43. Tien AL, Senbanerjee S, Kulkarni A, Mudbhary R, Goudreau B, Ganesan S, Sadler KC, Ukomadu C: UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis. Biochem J 2011, 435:175-185. 44. Unoki M, Nishidate T, Nakamura Y: ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 2004, 23:7601-7676. 45. Jenkins Y, Markovtsov V, Lang W, Sharma P, Pearsall D, Warner J, Franci C, Huang B, Huang J, Yam GC, Vistan JP, Pali E, Vialard J, Janicot M, Lorens JB, Payan DG, Hitoshi Y: Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Mol Biol Cell 2005, 16:5621-5629. 46. Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S, Ishikawa H, Saya H: Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/ WAF1-dependent DNAdamage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells 2004, 9:131-142. 47. Bostick M, Kim JK, Estève PO, Clark A, Pradhan S, Jacobsen SE: UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007, 317:1760-1764. 48. Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA, Shinga J, Mizutani-Koseki Y, Toyoda T, Okamura K, Tajima S, Mitsuya K, Okano M, Koseki H: The SRA protein Np95 mediates epigenetic inheritance by recruiting DNMT1 to methylated DNA. Nature 2007, 450:908-912. 49. Achour M, Jacq X, Rondé P, Alhosin M, Charlot C, Chataigneau T, Jeanblanc M, Macaluso M, Giordano A, Hughes AD, Schini-Kerth VB, Bronner C: The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. Oncogene 2008, 27:2187-2197. 50. Avvakumov GV, Walker JR, Xue S, Li Y, Duan S, Bronner C, Arrowsmith CH, Dhe-Paganon S: Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature 2008, 455:822-825. 51. Arita K, Ariyoshi M, Tochio H, Nakamura Y, Shirakawa M: Recognition of hemimethylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 2008, 455:818-821. 52. Hashimoto H, Horton JR, Zhang X, Bostick M, Jacobsen SE, Cheng X: The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 2008, 455:826-829. 53. Hashimoto H, Horton JR, Zhang X, Cheng X: UHRF1, a modular multi- domain protein, regulates replication-coupled crosstalk between DNA methylation and histone modifications. Epigenetics 2009, 4:8-14. 54. Achour M, Fuhrmann G, Alhosin M, Rondé P, Chataigneau T, Mousli M, Schini-Kerth VB, Bronner C: UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity. Biochem Biophys Res Commun 2009, 390:523-528. 55. Qin W, Leonhardt H, Spada F: Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1. J Cell Biochem 2011, 112:439-444. 56. Du Z, Song J, Wang Y, Zhao Y, Guda K, Yang S, Kao HY, Xu Y, Willis J, Markowitz SD, Sedwick D, Ewing RM, Wang Z: DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation- driven ubiquitination. Sci Signal 2010, 3:ra80. 57. Bronner C: Control of DNMT1 Abundance in Epigenetic Inheritance by Acetylation, Ubiquitylation, and the Histone Code. Sci Signal 2011, 4:pe3.